"State-of-the-Heart" Research Program
MCVI has one of the largest cardiovascular disease research programs in the Midwest. Our team of cardiologists, electrophysiologists and cardiovascular surgeons conduct nationally recognized drug and device studies to promote advances in diagnosis, treatment, and prevention of cardiovascular diseases.
Currently MCVI is involved in numerous research protocols and trials at the following hospitals: St. Mary's of Michigan, Covenant HealthCare, MidMichigan Medical Center-Midland and certain MCVI offices in Central and Northeastern Michigan, as well as the Thumb Area. Through research we are able to bring new cutting edge technologies to our physicians and the community.
Peter G. Fattal, MD serves as the Medical Director for Michigan CardioVascular Institute's Research program. He is responsible for oversight of all research protocols conducted within the MCVI program.
Safwan Kassas, MD serves as the Director of Cardiac Regenerative Medicine for Michigan CardioVascular Institute's Research program. You can read further about Dr. Kassas' studies here.
For more information on research studies, please click here.
For more information on the CISCRP (The Center for Information and Study on Clinical Research Participation), please click here.
If you have any questions and/or if you have questions about a patient that states they are currently enrolled in a research trial, please do not hesitate to notify us. This enables us to continue to collect required data and be sure programming requirements are maintained per study protocol. You can reach our Research Department by calling (989) 754-3555 ext. 4187 or toll-free 1-877-725-6284 ext. 4187.